Patients Discontinuing Weight-Loss Medications Put On Weight Four Times Faster Than Dieters

A recent study suggests that patients who stop using popular GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end traditional diet and exercise programs.

Research printed in a prominent health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"Individuals using such medications need to be informed of the risk of rapid rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery implies a return to original weight within about 18 months.

Comparing Treatments

The study, which reviewed dozens of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.

Scientists point out that individuals who shed pounds through lifestyle changes alone usually have a less rapid weight regain—perhaps 100 grams monthly—once they finish.

Explaining the Quick Regain

Nutrition scientists propose the way of the injections explains the amplified weight return.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."

A Lifelong Issue?

Medical guidelines recommend the injections for people with weight-linked health risks, alongside recommended diet and exercise modifications.

Professionals say that, due to the likelihood of relapse, the therapy is often long-term.

This view is echoed by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," akin to managing diseases like hypertension.

User Testimonies

Users who have come off the jabs report a sudden return of cravings.

"I experienced something that goes on and you're instantly starving," said one woman.

This difficulty is compounded if individuals have not developed sustainable lifestyle or habit changes during treatment.

Growing Use

Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest being substantial.

• Adoption is higher among females compared to men.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Finally, researchers stress that while the jabs are effective tools for shedding pounds, they are not a standalone solution and long-term success hinges on combined lifestyle changes.